Is NAM cheap yet ?The problem with this stock as a takeover target is its tricky 2 class share scheme. Growers and non-growers. Like AWB.Anyone know why they have fallen ?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
ASX Market Open: Rising Aussie markets to ignore Wall Street's Thanksgiving caution | November 28, 2024
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025